Jacobs Ian Seth 4
4 · Lomond Therapeutics Holdings, Inc. · Filed Nov 5, 2024
Insider Transaction Report
Form 4
Jacobs Ian Seth
DirectorPresident, CEO, CFO, Secretary10% Owner
Transactions
- Other
Common Stock
2024-11-01−75,000→ 175,000 total
Footnotes (1)
- [F1]As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 75,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.